The biotech industry is slowly learning that though investors were once eager to give money to budding innovative drug companies, "the gravy days are over," The Wall Street Journal's Jonathan Rockoff and Pui-Wing Tam say.
The biotech industry is slowly learning that though investors were once eager to give money to budding innovative drug companies, "the gravy days are over," The Wall Street Journal's Jonathan Rockoff and Pui-Wing Tam say.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.